Skip to main content

Table 6 Correlation analysis of proteolytic enzymes, CEA and CA 19-9 in colorectal cancer.

From: Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer

  Colorectal cancer
  Pvalue (correlation coefficient)
CATB/CATL P = 0.0001 (rS = 0.67)
CATB/uPA P = 0.03 (rS = 0.28)
CATB/PAI-1 P = 0.04 (rS = 0.27)
CATL/uPA P = 0.11 (rS = 0.21)
PAI-1/CATL P = 0.03 (rS = 0.27)
PAI-1/uPA P = 0.001 (rS = 0.41)
CEA/CA 19-9 P = 0.0003 (rS = 0.46)
CEA/CATB P = 0.002 (rS = 0.40)
CEA/CATL P = 0.06 (rS = 0.25)
CEA/uPA P = 0.70 (rS = 0.05)
CEA/PAI-1 P = 0.002 (rS = 0.40)
CA 19-9/CATB P = 0.005 (rS = 0.36)
CA 19-9/CATL P = 0.33 (rS = 0.13)
CA 19-9/uPA P = 0.46 (rS = 0.10)
CA 19-9/PAI-1 P = 0.005 (rS = 0.36)
  1. Correlation of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in patients with colorectal cancer (n = 56)
  2. Abbreviations: CATB: cathepsin B; CATL: cathepsin L; uPA: urokinase-type plasminogen activator, PAI-1: plasminogen activator inhibitor type-1; CEA: carcinoembryonic antigen; CA 19-9: carbohydrate antigen 19-9; rS: Spearman rank correlation coefficient